$NHI
National Health Investors Inc Stock $nhi

$nhi Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-Q Financial Statement

#000087786018000039 Filed on May 08, 2018

Income Statement

Concept	2018 Q1	2017 Q1
Revenue	$72.75M	$66.39M
YoY Change	9.58%	12.49%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.630M	$4.430M
YoY Change	4.51%	32.63%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$17.34M	$16.14M
YoY Change	7.38%	17.56%
% of Gross Profit
Operating Expenses	$33.58M	$32.24M
YoY Change	4.16%	17.94%
Operating Profit	$39.17M	$34.14M
YoY Change	14.73%	7.75%
Interest Expense	$11.61M	$11.66M
YoY Change	-0.4%	13.63%
% of Operating Profit	29.65%	34.15%
Other Income/Expense, Net
YoY Change
Pretax Income	$38.43M	$44.23M
YoY Change	-13.11%	39.59%
Income Tax
% Of Pretax Income
Net Earnings	$38.43M	$44.23M
YoY Change	-13.11%	35.16%
Net Earnings / Revenue	52.83%	66.62%
Basic Earnings Per Share	$0.93	$1.11
Diluted Earnings Per Share	$0.92	$1.10
COMMON SHARES
Basic Shares Outstanding	41.53M shares	39.95M shares
Diluted Shares Outstanding	41.58M shares	40.11M shares

Balance Sheet

Concept	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.200M	$5.700M
YoY Change	-43.86%	35.81%
Cash & Equivalents	$3.230M	$5.685M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$9.000M	$2.700M
Other Receivables	$102.0M	$77.00M
Total Short-Term Assets	$114.2M	$85.40M
YoY Change	33.72%	-12.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.286B	$2.268B
YoY Change	0.79%	23.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$8.200M	$4.100M
YoY Change	100.0%	7.89%
Total Long-Term Assets	$2.445B	$2.431B
YoY Change	0.6%	17.91%
TOTAL ASSETS
Total Short-Term Assets	$114.2M	$85.40M
Total Long-Term Assets	$2.445B	$2.431B
Total Assets	$2.559B	$2.516B
YoY Change	1.73%	16.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.50M	$21.60M
YoY Change	-23.61%	-12.9%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$79.30M	$83.00M
YoY Change	-4.46%	2.98%
LONG-TERM LIABILITIES
Long-Term Debt	$1.160B	$1.146B
YoY Change	1.27%	22.26%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.160B	$1.146B
YoY Change	1.27%	22.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$79.30M	$83.00M
Total Long-Term Liabilities	$1.160B	$1.146B
Total Liabilities	$1.240B	$1.229B
YoY Change	0.88%	20.51%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.289B	$1.255B
YoY Change	2.72%	15.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.320B	$1.287B
YoY Change
Total Liabilities & Shareholders Equity	$2.559B	$2.516B
YoY Change	1.73%	16.52%

Cashflow Statement

Concept	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	$38.43M	$44.23M
YoY Change	-13.11%	35.16%
Depreciation, Depletion And Amortization	$17.34M	$16.14M
YoY Change	7.38%	17.56%
Cash From Operating Activities	$48.88M	$48.68M
YoY Change	0.41%	17.87%
INVESTING ACTIVITIES
Capital Expenditures	-$14.40M	-$118.0M
YoY Change	-87.8%	1142.11%
Acquisitions
YoY Change
Other Investing Activities	-$5.200M	-$2.400M
YoY Change	116.67%	-50.0%
Cash From Investing Activities	-$19.59M	-$120.4M
YoY Change	-83.74%	742.5%
FINANCING ACTIVITIES
Cash Dividend Paid	$39.46M	$35.86M
YoY Change	10.02%	9.88%
Common Stock Issuance & Retirement, Net	-$56.00K	$79.80M
YoY Change	-100.07%
Debt Paid & Issued, Net		$196.0K
YoY Change		3.7%
Cash From Financing Activities	-$28.76M	$72.62M
YoY Change	-139.6%	-732.65%
NET CHANGE
Cash From Operating Activities	$48.88M	$48.68M
Cash From Investing Activities	-$19.59M	-$120.4M
Cash From Financing Activities	-$28.76M	$72.62M
Net Change In Cash	$536.0K	$853.0K
YoY Change	-37.16%	-94.5%
FREE CASH FLOW
Cash From Operating Activities	$48.88M	$48.68M
Capital Expenditures	-$14.40M	-$118.0M
Free Cash Flow	$63.28M	$166.7M
YoY Change	-62.04%	228.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q1	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	276000	USD
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000877860
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41532154	shares
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	NATIONAL HEALTH INVESTORS INC
CY2017Q4	nhi	Accounts Receivableand Other Assets AccountsReceivableandOtherAssets	5187000	USD
CY2018Q1	nhi	Accounts Receivableand Other Assets AccountsReceivableandOtherAssets	8963000	USD
CY2017Q1	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	789000	USD
CY2017Q1	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	0.95
CY2018Q1	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	1.00
CY2018Q1	nhi	Contingent Funding Commitment ContingentFundingCommitment	34850000	USD
CY2018Q1	nhi	Contingent Funding Commitment Remaining Unfunded Amount ContingentFundingCommitmentRemainingUnfundedAmount	31350000	USD
CY2018Q1	nhi	Credit Facility Current Revolving Borrowing Capacity CreditFacilityCurrentRevolvingBorrowingCapacity	550000000	USD
CY2018Q1	nhi	Debt Instrument Variable Rate Basis Minimum DebtInstrumentVariableRateBasisMinimum	0.00
CY2017Q1	nhi	Equity Issuance Costs EquityIssuanceCosts	0	USD
CY2018Q1	nhi	Equity Issuance Costs EquityIssuanceCosts	-56000	USD
CY2017Q1	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	267000	USD
CY2018Q1	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	346000	USD
CY2017Q1	nhi	Lessee Payment To Acquire Purchase Option LesseePaymentToAcquirePurchaseOption	1250000	USD
CY2018Q1	nhi	Lessee Payment To Acquire Purchase Option LesseePaymentToAcquirePurchaseOption	1275000	USD
CY2018Q1	nhi	Maximum Commitment For All Active Development Projects MaximumCommitmentForAllActiveDevelopmentProjects	88380000	USD
CY2018Q1	nhi	Nonemployeedirectorannualstockgrants Nonemployeedirectorannualstockgrants	25000	shares
CY2017Q4	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	1298000	USD
CY2018Q1	nhi	Notes Receivable Funding Commitment NotesReceivableFundingCommitment	41164000	USD
CY2018Q1	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	10	properties
CY2017Q4	nhi	Number Of Lessees NumberOfLessees	27
CY2017Q3	nhi	Real Estate Investment Property Portfolio Assets RealEstateInvestmentPropertyPortfolioAssets	2682387000	USD
CY2018Q1	nhi	Real Estate Properties Commitment To Purchase Amount RealEstatePropertiesCommitmentToPurchaseAmount	47017000	USD
CY2018Q1	nhi	Variable Interest Entity Number Of Entities Not Primary Beneficiary VariableInterestEntityNumberOfEntitiesNotPrimaryBeneficiary	8
CY2018Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	397538000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-822000	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	17476000	USD
CY2018Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	16514000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	380202000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1335000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1289919000	USD
CY2018Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1288861000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	-2427000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1523000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1425000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2018Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2017Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	104000	USD
CY2018Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	552000	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1337000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1069000	USD
CY2017Q1	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	10000	USD
CY2018Q1	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	63000	USD
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19851	shares
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	118639	shares
CY2017Q4	us-gaap	Assets Assets	2545821000	USD
CY2018Q1	us-gaap	Assets Assets	2559428000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4832000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5685000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3063000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3230000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	853000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	167000	USD
CY2017Q4	us-gaap	Cash Flow Hedge Derivative Instrument Liabilities At Fair Value CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue	588000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.00
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41532154	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41532154	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41532154	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41532154	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	415000	USD
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	415000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	35420000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	40354000	USD
CY2018Q1	us-gaap	Construction And Development Costs ConstructionAndDevelopmentCosts	41363000	USD
CY2017Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2678000	USD
CY2018Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	4781000	USD
CY2017Q4	us-gaap	Convertible Debt ConvertibleDebt	144938000	USD
CY2018Q1	us-gaap	Convertible Debt ConvertibleDebt	118041000	USD
CY2017Q4	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	32605000	USD
CY2018Q1	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	29270000	USD
CY2018Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1173129000	USD
CY2014Q1	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	7762000	USD
CY2018Q1	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	192238000	USD
CY2017Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	70.01
CY2017	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	14.28
CY2017	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	1714100	shares
CY2017Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.039
CY2018Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	3340000	USD
CY2018Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	9563000	USD
CY2017Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1145497000	USD
CY2018Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1160226000	USD
CY2017Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	97359000	USD
CY2018Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	102046000	USD
CY2017Q1	us-gaap	Depreciation Depreciation	16144000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	17335000	USD
CY2018Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	41532000	USD
CY2017Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	39456000	USD
CY2018Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	41532000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.11
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.93
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2018Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1707000	USD
CY2017Q4	us-gaap	Escrow Deposit EscrowDeposit	8208000	USD
CY2018Q1	us-gaap	Escrow Deposit EscrowDeposit	8208000	USD
CY2017Q1	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	10088000	USD
CY2018Q1	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	0	USD
CY2017Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	50000	USD
CY2018Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	USD
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-738000	USD
CY2017Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	50000	USD
CY2018Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4108000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4170000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.10
CY2018Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.92
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2306000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	641000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	657000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4245000	USD
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	98048	shares
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	56910	shares
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	44722	shares
CY2017Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	67000	USD
CY2018Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	24000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	11661000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	11614000	USD
CY2017Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	10033000	USD
CY2018Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	10527000	USD
CY2017Q1	us-gaap	Interest Income Operating InterestIncomeOperating	3089000	USD
CY2018Q1	us-gaap	Interest Income Operating InterestIncomeOperating	3460000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	9164000	USD
CY2018Q1	us-gaap	Interest Paid InterestPaid	9904000	USD
CY2018Q1	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	775000	USD
CY2017Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2471602000	USD
CY2018Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2485951000	USD
CY2017Q4	us-gaap	Land Land	191623000	USD
CY2018Q1	us-gaap	Land Land	192953000	USD
CY2017Q1	us-gaap	Legal Fees LegalFees	56000	USD
CY2018Q1	us-gaap	Legal Fees LegalFees	111000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	1223704000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	1239547000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2545821000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2559428000	USD
CY2017Q4	us-gaap	Line Of Credit LineOfCredit	221000000	USD
CY2018Q1	us-gaap	Line Of Credit LineOfCredit	262000000	USD
CY2018Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	800000000	USD
CY2018Q1	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	20
CY2018Q1	us-gaap	Loans And Leases Receivable Commitments Fixed Rates LoansAndLeasesReceivableCommitmentsFixedRates	117000000	USD
CY2017Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	141486000	USD
CY2018Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	145845000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	1155000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	409903000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	638340000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	121291000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	1196000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1244000	USD
CY2018Q1	us-gaap	Loss On Cash Flow Hedge Ineffectiveness LossOnCashFlowHedgeIneffectiveness	353000	USD
CY2017Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	10038000	USD
CY2018Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
CY2017Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	10038000	USD
CY2018Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	72622000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-28755000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-120444000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19586000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48675000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48508000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	44230000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	38432000	USD
CY2018Q1	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1 NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	235000	USD
CY2017Q1	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	824000	USD
CY2018Q1	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	290000	USD
CY2017Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	210	properties
CY2017Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	32
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	32236000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	33576000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	34142000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	39170000	USD
CY2017Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	63127000	USD
CY2018Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	69253000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	18212000	USD
CY2018Q1	us-gaap	Other Assets OtherAssets	22160000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8810000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1922000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	10038000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-789000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-276000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	465000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	1646000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-26000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2017Q1	us-gaap	Other Income OtherIncome	162000	USD
CY2018Q1	us-gaap	Other Income OtherIncome	33000	USD
CY2017Q1	us-gaap	Other Noncash Income OtherNoncashIncome	271000	USD
CY2018Q1	us-gaap	Other Noncash Income OtherNoncashIncome	436000	USD
CY2017Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	10088000	USD
CY2018Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2017Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	994000	USD
CY2018Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1812000	USD
CY2017Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	35863000	USD
CY2018Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	39456000	USD
CY2017Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	116000	USD
CY2018Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2017Q1	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	28338000	USD
CY2018Q1	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	5905000	USD
CY2017Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	118011000	USD
CY2018Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	14404000	USD
CY2017Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	3842000	USD
CY2018Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	0	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	79797000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2017Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	112000000	USD
CY2018Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	56000000	USD
CY2017Q1	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	450000	USD
CY2018Q1	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	0	USD
CY2017Q1	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	12109000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	2535000	USD
CY2017Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	18182000	USD
CY2017	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	18182000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2665903000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2683685000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2285701000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2286147000	USD
CY2017Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	196000	USD
CY2018Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	285000	USD
CY2017Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2018Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	29958000	USD
CY2017Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	83000000	USD
CY2018Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	15000000	USD
CY2017Q4	us-gaap	Replacement Reserve Escrow ReplacementReserveEscrow	4817000	USD
CY2018Q1	us-gaap	Replacement Reserve Escrow ReplacementReserveEscrow	4989000	USD
CY2017Q1	us-gaap	Revenues Revenues	66378000	USD
CY2018Q1	us-gaap	Revenues Revenues	72746000	USD
CY2017Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	21275000	USD
CY2018Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	21275000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1425000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.053
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.065
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.198
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.194
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0149
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0239
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	585827	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	949160	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.75
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.49
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	541679	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	979178	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	859182	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1404182	shares
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y11M2D
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y3M14D
CY2017Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1523000	USD
CY2018Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1425000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	1322117000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	1319881000	USD
CY2017Q1	us-gaap	Straight Line Rent StraightLineRent	5755000	USD
CY2018Q1	us-gaap	Straight Line Rent StraightLineRent	5962000	USD
CY2017Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	10453000	USD
CY2017Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	39953804	shares
CY2018Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	41532154	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40108762	shares
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41576876	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39953804	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41532154	shares
CY2017Q1	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	906000	USD
CY2018Q1	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	835000	USD
CY2018Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications</font><font style="font-family:inherit;font-size:10pt;"> - We have reclassified certain balances where necessary to conform the presentation of prior periods to the current period. These reclassifications had no effect on previously reported net income.</font></div></div>
CY2018Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates -</font><font style="font-family:inherit;font-size:10pt;"> The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates</font></div></div>

Files In Submission

Name	View Source	Status
0000877860-18-000039-index-headers.html	Edgar Link	pending
0000877860-18-000039-index.html	Edgar Link	pending
0000877860-18-000039.txt	Edgar Link	pending
0000877860-18-000039-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhi-20180331.xml	Edgar Link	completed
nhi-20180331.xsd	Edgar Link	pending
nhi-20180331_cal.xml	Edgar Link	unprocessable
nhi-20180331_def.xml	Edgar Link	unprocessable
nhi-20180331_lab.xml	Edgar Link	unprocessable
nhi-20180331_pre.xml	Edgar Link	unprocessable
nhi-3312018x10q.htm	Edgar Link	pending
nhi-3312018x10qex311.htm	Edgar Link	pending
nhi-3312018x10qex312.htm	Edgar Link	pending
nhi-3312018x10qex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHI
National Health Investors Inc Stock $nhi

2018 Q1 Form 10-Q Financial Statement

#000087786018000039 Filed on May 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI National Health Investors Inc Stock $nhi

2018 Q1 Form 10-Q Financial Statement

#000087786018000039 Filed on May 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI
National Health Investors Inc Stock $nhi